From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

REACH-B Advice

First published:

2022

Last published:

2022

Overview

This form is a platform through which s100 prescribers can submit cases and questions to seek specialist review and advice.

REACH-B Advice has been designed for current community hepatitis B s100 prescribing clinicians. It is not for community members or general clinicians. If you are not a prescriber but have a question for ASHM please [email protected].

The online Reach-B Form provides a time effective option to receive specialist support within 48 hours.

REACH-B Advice was developed in collaboration with the Kirby Institute at the University of NSW as a complement to their REACH-B Project.